20 February 2019

Smith+Nephew celebrates 18th year on FTSE4Good Index

Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is delighted to announce that the Company remains a constituent of the FTSE4Good Index Series following the December 2018 index review. This is Smith & Nephew’s 18th consecutive year in membership.

The FTSE4Good Series is designed to help market participants measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) for their investment decisions. The indexes identify environmentally and socially sustainable companies and act as a transparent and evolving global ESG standard and performance benchmark. The ESG ratings are used by market participants who wish to incorporate ESG factors into their investment decision-making processes, or as a framework for corporate engagement and stewardship.

In the latest review, Smith & Nephew scored well across all three pillars of sustainability – Environmental, Social and Governance. The Company’s best performance was in Climate Change and Governance, with improvements being made in Social Responsibility. The focus areas complement the important work Smith & Nephew is doing to meet its Sustainability goals.



Andrew Swift
Smith & Nephew
+44 (0) 20 7960 2285 


Charles Reynolds
Smith & Nephew
+44 (0) 1923 477314

About Smith & Nephew

Smith & Nephew is a portfolio medical technology business with leadership positions in Orthopaedics, Advanced Wound Management and Sports Medicine. Smith & Nephew has more than 16,000 employees and a presence in more than 100 countries. Annual sales in 2018 were $4.9 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN). For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com and follow us on Twitter, LinkedIn or Facebook.

 Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.